Interest of military forces and law enforcement agencies in non-lethal biochemical weapons has witnessed tremendous development in the recent past as progress in technology in science has appeared to provide the assurance of innovative non-lethal weapons, used in a wide variety of militarily and politically threatening situations. These weapons, also known as less than lethal biochemical weapons, intend to be less probable for killing living targets than traditional firearms or knives. These devices are specialized munitions which use chemicals calibrated to inflict injury or harm to human beings, and organisms or pathogens to cause disease. These pathogens may include viruses, bacteria, toxins or fungi.
Rising defense expenditure by the governments of economies that are considered emerging, such as India, China, Turkey and South Korea, is projected to provide many development opportunities for the stakeholders in the global non-lethal biochemical weapons market space. Besides, the increasing research and development within this field is anticipated to boost the growth prospects of these weapons during the forecast period.
However, the development of the non-lethal biochemical weapons can be impacted by certain definite restraining factors in the near future. These restraints include a decline in the defense budget of developed countries, and stringent governmental and environmental regulations.
The opportunities of demand in the global non-lethal biochemical weapons market are the result of different incidents of civil conflicts and unrest in South Asia, the Middle East, and the North African regions. These zones have been recognized as highly dynamic markets for non-lethal biochemical weapons, because of the exponential rates of demand growth in the recent past. For instance, the sectarian unrest in Lebanon, the Syrian civil war, and the political viciousness in Jerusalem call for enhanced response by the military as well as law enforcement agencies. As a consequence, the securing of non-lethal biochemical weapons by military forces is expected to rise substantially during the forecast period. Thus the dynamic global market for these weapons has high potential. So the opportunities of the market could be accredited to the transforming political and regional dynamics of the world economy, rising incidences of armed terrorism and violence.
Based on the various non-lethal biochemical weapons operations, the global market is segmented into defensive, offensive, and genetic attack. Swift growth in demand for genetic attack weapons is a major factor to boost the demand for non-lethal biochemical weapons, globally. On the basis of product type, this market is segmented into directed energy weapons (DEW), and direct contact weapons. Non-lethal biochemical weaponry in the directed energy segment has accounted for an astounding pace of consolidation, because of giant industrial conglomerates taking over smaller organizations rapidly. With respect to end use, the global non-lethal biochemical weapons market can be segmented into law enforcement agencies and military forces.
By geography, the global non-lethal biochemical Weapons market has been classified into five regions namely North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. Currently, the Middle East and Africa segment held the major share of the market, followed by North America, Asia Pacific, Europe, and Latin America. The Asia Pacific region is expected to develop rapidly with rising trade with North America and Europe. Regional players have been focusing on partnerships with players in regions such as Africa.
The leading manufacturing companies profiled in this report are BAE Systems, Inc.; Lamperd Less Lethal, Inc., Taser International, Inc.; Raytheon Company; Textron Systems, Corp.; General Dynamics Corporation; Chemring Group PLC.; Moog, Inc; Qinetiq Group, Inc.; and LRAD Corporation. These organizations focus on evolving innovative products after investment of substantial amount of their net sales in research and development for introducing progressive technologies with large range abilities, reduced weight, and relatively higher precision.
The segments covered in the Non-Lethal Biochemical Weapons market are as follows:
Global Non-Lethal Biochemical Weapons Market: By Operation Type
• Genetic Attack
Global Non-Lethal Biochemical Weapons Market: By Product Type
• Directed Energy
• Direct Contact
Global Non-Lethal Biochemical Weapons Market: By End Use
• Military Forces
• Law Enforcement Agencies
Global Non-Lethal Biochemical Weapons Market: By Geography
• North America
Rest of Europe
• Asia Pacific
Rest of Asia Pacific
• Middle East and Africa
Rest of MEA
• Latin America
Rest of Latin America